Requests that the FDA confirm that Hydrochlorothiazide Oral Suspension is suitable for submission in an Abbreviated New Drug Application.
🏛 Food and Drug Administration (FDA)FDA-2025-P-7285
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Dec 22, 2025No comment period